Research programme: allergy immunotherapeutics - SanofiAlternative Names: Food allergy vaccine - Immune Design/Sanofi; Grass pollen allergy vaccine - Immune Design/Sanofi
Latest Information Update: 22 Mar 2016
At a glance
- Originator Sanofi
- Developer Immune Design; Sanofi
- Class Allergy immunotherapies; Food allergy immunotherapies
- Mechanism of Action Immunomodulators; Toll-like receptor 4 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Food hypersensitivity; Hypersensitivity